The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products ...

There are currently shortages of the Fiasp FlexTouch insulin pen which could affect people living with diabetes who take Fiasp insulin. Here’s what you need to know.

Tala Motazedi, a queer screenwriter from Iran, has had a very busy year indeed as the PEN Writer-in-Residence at George Brown College. Her work at the College began in September. … ...

Insulin allows cells to absorb and use glucose. In people with insulin resistance, the cells are unable to use insulin effectively. Insulin resistance occurs when cells in the body do not respond ...

We may earn a commission if you make a purchase from the links on this page. The high-end Galaxy S25 Ultra's S Pen doesn't support Bluetooth, so it loses some cool features like remote control for ...